Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
The cost-effectiveness of screening for colorectal cancer
R Crott
Acta Psychiatrica Scandinavica
|
May 7, 1998
Economic comparisons of the pharmacotherapy of depression: an overview
R Crott, P Gilis
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2002
Health Economics Unit achievements
R Crott, N Neymark
Controlled Clinical Trials
|
February 1, 1997
The difference in mean costs as a pharmacoeconomic outcome variable: power considerations
A Bouckaert, R Crott
The Canadian Journal of Urology
|
December 19, 2000
Economic evaluation of NMP22 in the management of bladder cancer
J Lachaine, L Valiquette, R Crott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 29, 2004
Cost-utility of adjuvant high-dose interferon alpha therapy in stage III cutaneous melanoma in Quebec
R Crott, F Ali, S Burdette-Radoux
Pharmacoeconomics
|
February 7, 1996
Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experience
M C Closon, R Crott, D Even-Adin
Health Technology Assessment (Winchester, England)
|
March 2, 2011
Growth monitoring for short stature: update of a systematic review and economic model
D Craig, D Fayter, L Stirk, et al.
Acta Psychiatrica Scandinavica
|
November 27, 2012
Economic impact of antidepressant treatment duration in naturalistic conditions
M Tournier, R Crott, Y Gaudron, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
November 7, 2013
A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation
B Krug, R Crott, L de Cannière, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
The cost-effectiveness of screening for colorectal cancer
R Crott
Acta Psychiatrica Scandinavica
|
May 7, 1998
Economic comparisons of the pharmacotherapy of depression: an overview
R Crott, P Gilis
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2002
Health Economics Unit achievements
R Crott, N Neymark
Controlled Clinical Trials
|
February 1, 1997
The difference in mean costs as a pharmacoeconomic outcome variable: power considerations
A Bouckaert, R Crott
The Canadian Journal of Urology
|
December 19, 2000
Economic evaluation of NMP22 in the management of bladder cancer
J Lachaine, L Valiquette, R Crott
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 29, 2004
Cost-utility of adjuvant high-dose interferon alpha therapy in stage III cutaneous melanoma in Quebec
R Crott, F Ali, S Burdette-Radoux
Pharmacoeconomics
|
February 7, 1996
Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experience
M C Closon, R Crott, D Even-Adin
Health Technology Assessment (Winchester, England)
|
March 2, 2011
Growth monitoring for short stature: update of a systematic review and economic model
D Craig, D Fayter, L Stirk, et al.
Acta Psychiatrica Scandinavica
|
November 27, 2012
Economic impact of antidepressant treatment duration in naturalistic conditions
M Tournier, R Crott, Y Gaudron, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
November 7, 2013
A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation
B Krug, R Crott, L de Cannière, et al.
Page
of 2